Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2014

Comprehensive molecular characterization of urothelial bladder carcinoma. Nature. 2014;507(7492):315-22.

Samad A, Attam R, Jessurun J, Pambuccian SE. Psammoma bodies and abundant stromal amyloid in an endoscopic ultrasound guided fine needle aspirate (EUS-FNA) of a pancreatic neuroendocrine tumor: a potential pitfall. Diagn Cytopathol. 2014;42(9):766-71.

Pekkonen P, Järviluoma A, Zinovkina N, Cvrljevic A, Prakash S, Westermarck J, et al. KSHV viral cyclin interferes with T-cell development and induces lymphoma through Cdk6 and Notch activation in vivo. Cell Cycle. 2014;13(23):3670-84.

Branda JA, Rychert J, Burnham C-, Bythrow M, Garner OB, Ginocchio CC, et al. Multicenter validation of the VITEK MS v2.0 MALDI-TOF mass spectrometry system for the identification of fastidious gram-negative bacteria. Diagn Microbiol Infect Dis. 2014;78(2):129-31.

Magro CM, Hagen JW, Crowson AN, Liu YC, Mihm M, Drucker NM, et al. Hypopigmented interface T-cell dyscrasia: a form of cutaneous T-cell dyscrasia distinct from hypopigmented mycosis fungoides. J Dermatol. 2014;41(7):609-17.

DeSimone RA, Ginter PS, Chen Y-. Granular cell tumor of the breast eliciting exuberant pseudoepitheliomatous hyperplasia. Int J Surg Pathol. 2014;22(2):156-7.

Hagen JW, Magro CM. Indolent CD8+ lymphoid proliferation of the face with eyelid involvement. Am J Dermatopathol. 2014;36(2):137-41.

Greenblatt MB, Torre M, Means J, Tanasijevic M, Pedulla LV, Bunnell CA, et al. Use of potassium concentrations as a quality-of-service metric for phlebotomists detects systematic preanalytical biases and facilitates their correction. Clin Chem. 2014;60(11):1453-5.

Khani F, Mosquera JM, Park K, Blattner M, O'Reilly C, MacDonald TY, et al. Evidence for molecular differences in prostate cancer between African American and Caucasian men. Clin Cancer Res. 2014;20(18):4925-34.

Vitolo U, Chiappella A, Franceschetti S, Carella AM, Baldi I, Inghirami G, et al. Lenalidomide plus R-CHOP21 in elderly patients with untreated diffuse large B-cell lymphoma: results of the REAL07 open-label, multicentre, phase 2 trial. Lancet Oncol. 2014;15(7):730-7.